Abstract
This study aimed to screen potential genes related to thyroid-associated ophthalmopathy (TAO) and get a further understanding about the pathogenesis of this disease. GSE9340 was downloaded from Gene Expression Omnibus, including eight thyroid tissue samples from hyperthyroid patients without TAO and ten ones from hyperthyroid patients with TAO. The differentially expressed genes (DEGs) were identified by the linear models for microarray data package. And their potential functions were predicted by Gene Ontology (GO) and pathway enrichment analyses. Furthermore, protein-protein interaction (PPI) was obtained from the Search Tool for the Retrieval of Interacting Genes database, and the PPI network was visualized with Cytoscape. Then, module analysis was performed by the Molecular Complex Detection analysis. Additionally, the potential pathway interactions were identified by Latent Pathway Identification Analysis. Totally, 511 upregulated and 507 downregulated DEGs in TAO were screened. Some DEGs (e.g., UBE2C) were related to cell cycle, and DEGs encoding proteasome (e.g., PSMA1, PSMC5, PSMC4, and PSMD1) were related to negative regulation of ubiquitin-protein ligase activity. Several upregulated DEGs encoding signal recognition particle (e.g., SRP14, SRP54, and SRP9) were found to be enriched in protein export pathway. Furthermore, some pathways (e.g., ribosome and protein export) had interactions. The DEGs related to cell cycle (e.g., UBE2C), DEGs encoding proteasome (e.g., PSMA1, PSMC5, PSMC4, and PSMD1) and signal recognition particle (e.g., SRP14, SRP54, and SRP9), as well as pathways of ribosome, protein export and retinol metabolism, might play key roles in the development of TAO.
Similar content being viewed by others
References
Heufelder AE, Weetman AP, Ludgate M, Bahn RS Pathogenesis of Graves’ ophthalmopathy. Recent developments in Graves’ ophthalmopathy. 15-37, 2000.
Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol 120: 473-478, 1989.
Weetman AP Graves' disease. New Engl J Med 343: 1236-1248, 2000.
Minakaran N, Ezra DG Rituximab for thyroid-associated ophthalmopathy. Cochrane Database Syst Rev, 2013.
Chung SA, Jeon BK, Choi YH, Back KO, Lee JB, Kook KH Pirfenidone attenuates the IL-1β–induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55: 2276-2283, 2014.
Wiersinga WM Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96: 2386-2394, 2011.
Gopinath B, Wescombe L, Nguyen B, Wall JR Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease? Orbit 28: 256-261, 2009.
Wescombe L, Lahooti H, Gopinath B, Wall JR The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy–support for a role of autoimmunity against calsequestrin as the triggering event. Clin Endocrinol 73: 522-528, 2010.
Edgar R, Domrachev M, Lash AE Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210, 2002.
Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 99: 909-917, 2004.
Diboun I, Wernisch L, Orengo CA, Koltzenburg M Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7: 252, 2006.
Huang da W, Sherman BT, Lempicki RA Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
Szklarczyk D, Franceschini A, Kuhn M et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-568, 2011.
Shannon P, Markiel A, Ozier O et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003.
Bader GD, Hogue CW An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4: 2, 2003.
Pham L, Christadore L, Schaus S, Kolaczyk ED Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis. Proc Natl Acad Sci USA 108: 13347-13352, 2011.
Nyström E, Berg GE, Jansson SK, Tørring O, Valdemarsson SV. Symptoms of thyrotoxicosis. Thyroid disease in adults. 139-143, 2010.
Garrity JA, Bahn RS Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol 142: 147-153, 2006.
Vaux DL, Flavell RA Apoptosis genes and autoimmunity. Curr Opin Immunol 12: 719-724, 2000.
Pogribny IP, Muskhelishvili L, Tryndyak VP, Beland FA The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol Appl Pharmacol 235: 305-311, 2009.
Wan L, Tan M, Yang J et al. APC (Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. Dev Cell 29: 377-391, 2014.
Cheng KC, Huang HH, Hung CT et al. Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy. Graefs Arch Clin Exp Ophthalmol 251: 2777-2787, 2013.
Zhao P, Deng Y, Gu P et al. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy. Exp Eye Res 107: 65-73, 2013.
Saben J, Kang P, Zhong Y et al. RNA-seq analysis of the rat placentation site reveals maternal obesity-associated changes in placental and offspring thyroid hormone signaling. Placenta 35: 1013-1020, 2014.
Gillespie EF, Papageorgiou KI, Fernando R et al. Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab 97: E740-E746, 2012.
Acknowledgments
This research was supported by the Project of Science and Technology Foundation of Medical School of Shanghai Jiaotong University (13XJ10047).
Conflict of Interest
None of the authors has conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Pingqian Zhao and Haitao Yin contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhao, P., Yin, H., Tao, C. et al. Latent Pathways Identification by Microarray Expression Profiles in Thyroid-Associated Ophthalmopathy Patients. Endocr Pathol 26, 200–210 (2015). https://doi.org/10.1007/s12022-015-9373-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-015-9373-8